Medichem SA is a Spanish company located in Sant Joan Despi that manufactures and supplies pharmaceutical ingredients. The firm was founded in 1972. José Luis Rodríguez is the CEO, in this role since 1996.

Time Chemical is a producer of electrolytic fluorine chemicals. Time Chemical's production bases are based in Jiang province, Sham province, Xinjiang province, and Inner Mongolia province, which covers an area of more than 200 hectares in total.

CSSC (Handan) Perry Special Gas Co., Ltd., established on 2016-12-21, Business scope includes licensed projects:Hazardous Chemical Production;Hazardous Chemicals Management;Portable Pressure Vessel/Cylinder filling.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Research and development of special electronic materials;Electronic special material manufacturing;Sales of electronic special materials;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Rare rare earth metal smelting;New material technology research and development;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

BASF AB supplies raw materials to paper, chemicals, and construction industries. Its products include construction chemical, crop protection products, dispersions and pigments, plastics, polyurethane systems and coating products. The company was founded in 1953 and is headquartered in Göteborg, Sweden.

Manufactures and sells pharmaceuticals

Quantum Genomics SA is a biopharmaceutical company, which develops new medication class for cardiovascular disease, such as high blood pressure and heart failure. It engages in research programs, that are based on the brain inhibition mechanism of aminopeptidase. The company was founded by Lionel Ségard on December 23, 2005 and is headquartered in Paris, France.

Eastman Chemical Co. engages in the provision of specialty chemicals. It operates through the following segments: Advanced Material (AM), Additives and Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The AM segment produces and markets its polymers, films, and plastics with differentiated performance properties for value-added end uses in transportation, consumables, building and construction, durable goods, and health and wellness markets. The AFP segment includes chemicals for products in the transportation, consumables, building and construction, animal nutrition, crop protection, energy, personal and home care, and other markets. The CI segment consists of large scale and vertical integration from the cellulose and acetyl, olefins, and alkylamines streams to support operating segments with advantaged cost positions. The Fibers segment offers cellulose acetate tow for use in filtration media, primarily cigarette filters. The company was founded by George Eastman in 1920 and is headquartered in Kingsport, TN.

Shanshan New Materials (Quzhou) Co., Ltd., established on 2013-05-20, Business scope includes licensed projects:Hazardous Chemical Production;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:New material technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products);Non-ferrous metal alloy sales;Sales of electronic components and electromechanical components;Business Management Consulting(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Taizhou Dachen Pharmaceutical Co., Ltd., established on 2017-11-09, Business scope includes general items:Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Biochemical product technology research and development;New material technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Hazardous Chemical Production;pharmaceutical production;Pharmaceutical commissioned production;second,Phosphorus contained in Class III monitored chemicals and Class IV monitored chemicals,sulfur,Production of Fluorine Specific Organic Chemicals(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Lanzhou Minuo Biotechnology Co., Ltd., established on 2010-10-26, Business scope includes fine chemical products(Does not contain hazardous chemicals and business scope prohibited by the state)R & D and sales(The above items are prohibited by the state and require special permission except)****

Toray Industries, Inc. (東レ株式会社 Tōre Kabushiki-gaisha) is a multinational corporation headquartered in Japan that specializes in industrial products centered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry.

Jiming Pharmaceutical Technology (Suzhou) Co., Ltd., established on 2011-08-18, The business scope includes new drug research and development of compounds and bioengineering,Selling Lab Samples,Provide technology transfer;Wholesale of pharmaceutical intermediate products,import and export,commission agent(except auction);drug sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Mitsubishi Materials Corp. engages in the manufacture and sale of cement, metals, ceramics, and other industrial materials. It operates through the following segments: High-Performance Products, Processing business, Metal business, Cement business and Other business. The High-Performance Products segment manufactures and sells copper processed products, functional materials, electronic devices, chemical products, polycrystalline silicon and Aerosil. The Processing business manufactures and sells carbide products and sintered products. The Metal business smelts and sells Copper, gold and silver. The Cement Business segment manufactures and sells cement and ready-mixed concrete. The Other Business involves in geothermal and hydroelectric power generation business, environmental recycle business, real estate, Civil engineering, construction, repair work and geological survey. The company was founded by Yataro Iwasaki in May 1871 and is headquartered in Tokyo, Japan.

Suzhou Kangrun Pharmaceutical Co., Ltd., established on 2010-01-06, Business scope includes pharmaceutical products,Research and development of pharmaceutical intermediates,Provide relevant technical advice,technology transfer,Technical Services;Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:pharmaceutical production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Kamek (Shanghai) Pharmaceutical Technology Co., Ltd., established on 2019-04-25, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:engaged in medical technology,Biological Technology,Chemical Technology,Environmental Technology,Technology development in the field of laboratory equipment,Technical Services,technology transfer,technical consulting;Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Class I medical device,Laboratory Equipment Sales;Glass instrument processing;Business Management Consulting;e-commerce(Not allowed to engage in value-added telecommunications,Financial services);Production of Class I Medical Devices;Sales of Class II Medical Devices;Engaged in the production of molecular building blocks and high-purity reagents(Removal of hazardous chemicals);The following limit branch operation:Biopharmaceutical Intermediates(In addition to drugs)research and development,Production,Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.